Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Licht

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Blood|December 16, 2017
SETD2: a complex role in blood malignancyJonathan D Licht
Blood|July 3, 2020
Oncogenesis by E2A-PBX1 in ALL: RUNX and moreJonathan D Licht
The New England Journal of Medicine|February 28, 2009
Acute promyelocytic leukemia--weapons of mass differentiationJonathan D Licht
Cancer Discovery|December 2, 2020
Histone H3 G34 Tail Mutations in Cancer: Actions in <i>Cis</i> and <i>Trans</i> to Alter Chromatin and Gene ExpressionJonathan D Licht
Transactions of the American Clinical and Climatological Association|September 1, 2018
DISORDERED HISTONE METHYLATION IN HEMATOLOGICAL MALIGNANCIES THE CASE OF UTX/KDM6AJonathan D Licht
Cancer Cell|February 14, 2006
Reconstructing a disease: What essential features of the retinoic acid receptor fusion oncoproteins generate acute promyelocytic leukemia?Jonathan D Licht
Cell|August 29, 2015
DNA Methylation Inhibitors in Cancer Therapy: The Immunity DimensionJonathan D Licht
Cancer Cell|June 15, 2007
Chromatin modulation by oncogenic transcription factors: new complexity, new therapeutic targetsItsaso Hormaeche, Jonathan D Licht
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2013
Ponatinib--a step forward in overcoming resistance in chronic myeloid leukemiaOlga Frankfurt, Jonathan D Licht
Current Opinion in Hematology|February 28, 2008
New molecular concepts and targets in acute myeloid leukemiaMonica Buzzai, Jonathan D Licht
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Blood|December 16, 2017
SETD2: a complex role in blood malignancyJonathan D Licht
Blood|July 3, 2020
Oncogenesis by E2A-PBX1 in ALL: RUNX and moreJonathan D Licht
The New England Journal of Medicine|February 28, 2009
Acute promyelocytic leukemia--weapons of mass differentiationJonathan D Licht
Cancer Discovery|December 2, 2020
Histone H3 G34 Tail Mutations in Cancer: Actions in <i>Cis</i> and <i>Trans</i> to Alter Chromatin and Gene ExpressionJonathan D Licht
Transactions of the American Clinical and Climatological Association|September 1, 2018
DISORDERED HISTONE METHYLATION IN HEMATOLOGICAL MALIGNANCIES THE CASE OF UTX/KDM6AJonathan D Licht
Cancer Cell|February 14, 2006
Reconstructing a disease: What essential features of the retinoic acid receptor fusion oncoproteins generate acute promyelocytic leukemia?Jonathan D Licht
Cell|August 29, 2015
DNA Methylation Inhibitors in Cancer Therapy: The Immunity DimensionJonathan D Licht
Cancer Cell|June 15, 2007
Chromatin modulation by oncogenic transcription factors: new complexity, new therapeutic targetsItsaso Hormaeche, Jonathan D Licht
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2013
Ponatinib--a step forward in overcoming resistance in chronic myeloid leukemiaOlga Frankfurt, Jonathan D Licht
Current Opinion in Hematology|February 28, 2008
New molecular concepts and targets in acute myeloid leukemiaMonica Buzzai, Jonathan D Licht
Pageof 18